Go Pro
Mason Carrico

Mason Carrico Analyst Performance

Research Analyst at Stephens

Mason Carrico is a stock analyst at Stephens in the healthcare sector, covering 15 publicly traded companies. Over the past year, Mason Carrico has issued 14 stock ratings, including strong buy, buy, and hold recommendations. While full access to Mason Carrico's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mason Carrico's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
31 Last 4 Years
Buy Recommendations
93.55% 29 Buy Ratings
Companies Covered
15 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy3.2%1 ratings
Buy90.3%28 ratings
Hold6.5%2 ratings
Sell0.0%0 ratings

Out of 31 total stock ratings issued by Mason Carrico at Stephens, the majority (90.3%) have been Buy recommendations, followed by 6.5% Hold and 3.2% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
15 companies

Mason Carrico, an analyst at Stephens, currently covers 15 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
15 companies
100.0%

Mason Carrico of Stephens specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
5 companies
33.3%
LIFE SCIENCES TOOLS & SERVICES
4 companies
26.7%
HEALTHCARE PROVIDERS & SERVICES
3 companies
20.0%
HEALTHCARE EQUIPMENT & SUPPLIES
3 companies
20.0%

About Mason Carrico

Mason is a research analyst covering the diagnostics and medical technologies sector. Mason holds a Master of Finance degree from Tulane University where he graduated Beta Gamma Sigma from the Freeman School of Business and a B.A. in Molecular, Cellular, and Developmental Biology from the University of Colorado at Boulder.
Follow on LinkedIn

Mason Carrico's Ratings History at Stephens

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Guardant Health, Inc. stock logo
GH
Guardant Health
8/4/2026Boost Price Target$158.83$195.00Overweight
Veracyte, Inc. stock logo
VCYT
Veracyte
8/4/2026Lower Price Target$44.85$55.00Overweight
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
7/23/2026Initiated Coverage$8.06$15.00Overweight
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
7/23/2026Initiated Coverage$8.06$15.00Overweight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
7/23/2026Initiated Coverage$106.07$160.00Overweight
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
7/23/2026Initiated Coverage$8.21$15.00Overweight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
7/22/2026Upgrade$107.67Strong-Buy
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
5/13/2026Lower Price Target$3.96$4.75Overweight
Natera, Inc. stock logo
NTRA
Natera
11/13/2025Boost Price Target$207.12$235.00Overweight
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
11/10/2025Boost Price Target$1.76$2.00Overweight
Hologic, Inc. stock logo
HOLX
Hologic
10/22/2025Downgrade$73.97$76.00Equal Weight
Hologic, Inc. stock logo
HOLX
Hologic
9/18/2025Reiterated Rating$68.20$78.00Overweight
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
9/2/2025Boost Price Target$8.78$11.00Overweight
Natera, Inc. stock logo
NTRA
Natera
8/15/2025Reiterated Rating$158.44$183.00Overweight
Vericel Corporation stock logo
VCEL
Vericel
6/16/2025Reiterated Rating$42.96$67.00Overweight
Illumina, Inc. stock logo
ILMN
Illumina
5/20/2025Reiterated Rating$82.95$105.00Overweight
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
5/15/2025Reiterated Rating$1.10$1.80Overweight
10x Genomics stock logo
TXG
10x Genomics
5/15/2025Reiterated Rating$9.15$14.00Overweight
Hologic, Inc. stock logo
HOLX
Hologic
5/13/2025Lower Price Target$57.32$70.00Overweight
CareDx, Inc. stock logo
CDNA
CareDx
5/5/2025Reiterated Rating$15.00$40.00Overweight
Veracyte, Inc. stock logo
VCYT
Veracyte
3/26/2025Reiterated Rating$32.68$45.00Overweight
Guardant Health, Inc. stock logo
GH
Guardant Health
3/26/2025Reiterated Rating$46.39$55.00Overweight
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
3/19/2025Reiterated Rating$4.32$6.00Overweight
Illumina, Inc. stock logo
ILMN
Illumina
3/11/2025Reiterated Rating$87.08$156.00Overweight
CareDx, Inc. stock logo
CDNA
CareDx
2/27/2025Reiterated Rating$21.81$40.00Overweight
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2/14/2025Reiterated Rating$1.69$2.50Overweight
Hologic, Inc. stock logo
HOLX
Hologic
2/6/2025Reiterated Rating$67.44$84.00Overweight
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
1/16/2025Reiterated Rating$12.40$20.00Equal Weight